Here is a comprehensive overview of the treatment of hyperhidrosis (excessive sweating), based on dermatology textbooks:
Treatment of Hyperhidrosis (Excessive Sweating)
Hyperhidrosis is divided into primary focal (palmoplantar, axillary) and secondary generalized forms. Treatment is stepwise, starting with the least invasive options.
Step 1 — Treat Underlying Cause (Generalized Hyperhidrosis)
Secondary (generalized) hyperhidrosis can result from:
- Systemic diseases: hyperthyroidism, acromegaly, diabetes, pheochromocytoma, lymphoma, carcinoid syndrome, menopause
- Drugs: SSRIs, TCAs, anticholinesterases, opioids, bladder stimulants
Therapy for generalized hyperhidrosis focuses on treating the underlying disease.
Step 2 — Topical Antiperspirants (First-Line for Focal Disease)
Aluminum chloride / aluminum chlorohydroxide are the most commonly used topical agents:
- Axillae: 10–35% solution applied nightly to completely dry skin (blow-dry first); wash off after 6–8 hours; occlusion usually not needed
- Palms/soles: Up to 50% concentration, applied nightly alone or occluded with plastic gloves
- Once effective, frequency can be reduced to 1–2×/week for maintenance
- Topical glycopyrrolate also reduces axillary hyperhidrosis
Step 3 — Iontophoresis (Localized Device Therapy)
- Tap water iontophoresis is an effective local alternative, particularly for palmoplantar disease
- 20–30 minute sessions, daily or twice daily until response, then intermittent maintenance (as infrequently as every 2 weeks)
- Adding glycopyrrolate 0.01%, botulinum toxin, or aluminum chloride 2% to the iontophoresis medium may hasten response
- Blocks sweat ducts at the stratum corneum
Step 4 — Botulinum Toxin Injections (Most Effective Before Surgery)
This should be offered to all patients who fail topical treatments before surgical options are considered.
| Site | Dose | Notes |
|---|
| Axillae | 50–100 units Botox/axilla (up to 200 units Dysport) | Intradermal grid, 1–2 cm apart; anhidrosis in 72 hrs–1 week; lasts 4–12 months (up to 29 months with Dysport) |
| Palms | 100–150 units Botox/palm | Requires wrist nerve blocks (median, ulnar, radial); temporary hand weakness for ~3 weeks; anhidrosis 4–12 months |
| Soles | Doses similar to palms | Pain management required |
- FDA-approved for axillary hyperhidrosis (onabotulinumtoxinA)
- Frey syndrome remits for 1–10 years in nearly all patients treated
- Repeated injections do not lose efficacy
Step 5 — Systemic (Oral) Medications
Anticholinergics block acetylcholine at eccrine glands:
- Glycopyrrolate, oxybutynin (also available extended-release), propantheline bromide
- Doses titrated to tolerance; often limited by anticholinergic side effects (dry mouth, urinary retention, blurred vision, constipation)
- Caution: may worsen glaucoma or precipitate convulsions
- Duration of effect ~4–6 hours; many patients use only for special occasions
- Other agents with reported benefit: diltiazem, clonidine
Step 6 — Energy-Based Devices
- Microwave thermolysis (miraDry): selectively heats the dermal-hypodermal junction, thermally destroying eccrine and apocrine glands; high patient satisfaction; side effects include transient edema, erythema, pain, and (longer-term) fibrous bands or muscle weakness
- Radiofrequency via microneedles and laser treatment: appear effective but require further study
Step 7 — Surgical Treatments
Axillary hyperhidrosis:
- Excision of the most actively sweating skin + undercutting/subcutaneous resection of sweat glands 1–2 cm beyond the excision margin — virtually always effective
- Alternatives: liposuction, surgical ultrasonic aspiration
- Preoperative mapping with starch-iodine or cobalt chloride is critical; active eccrine glands are not always co-located with axillary hair
- Note: botulinum toxin injections were superior to suction-curettage surgery in a comparative trial
Palmoplantar / severe generalized:
- Endoscopic thoracic sympathectomy (ETS) / sympathotomy: produces long-term benefit; however, compensatory hyperhidrosis occurs in up to one-third of patients — a serious concern given the large body surface area affected
Summary Algorithm
Topical aluminum chloride
↓ (if fails)
Iontophoresis
↓ (if fails)
Botulinum toxin injection
↓ (if fails)
Oral anticholinergics / energy devices
↓ (if fails)
Surgery (excision/liposuction for axillae; sympathectomy for palms)
— Andrews' Diseases of the Skin, pp. 892–893 | Fitzpatrick's Dermatology, pp. 3957–3958 | Goldman-Cecil Medicine, p. 1354